nodes	percent_of_prediction	percent_of_DWPC	metapath
Ifosfamide—testicular cancer—kidney cancer	0.419	1	CtDrD
Ifosfamide—PTGS1—kidney cancer	0.154	1	CbGaD
Ifosfamide—CYP3A7—Temsirolimus—kidney cancer	0.0274	0.0985	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.0274	0.0985	CbGbCtD
Ifosfamide—CYP3A5—Temsirolimus—kidney cancer	0.0205	0.0739	CbGbCtD
Ifosfamide—CYP3A4—Everolimus—kidney cancer	0.0118	0.0426	CbGbCtD
Ifosfamide—CYP2C8—Pazopanib—kidney cancer	0.0104	0.0373	CbGbCtD
Ifosfamide—CYP3A7—Paclitaxel—kidney cancer	0.00939	0.0338	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.00939	0.0338	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00834	0.03	CbGbCtD
Ifosfamide—CYP3A7—Sorafenib—kidney cancer	0.00834	0.03	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.0081	0.0291	CbGbCtD
Ifosfamide—CYP3A7—Vincristine—kidney cancer	0.0081	0.0291	CbGbCtD
Ifosfamide—CYP3A4—Temsirolimus—kidney cancer	0.008	0.0288	CbGbCtD
Ifosfamide—CYP2B6—Sorafenib—kidney cancer	0.00794	0.0286	CbGbCtD
Ifosfamide—CYP3A5—Erlotinib—kidney cancer	0.00769	0.0277	CbGbCtD
Ifosfamide—CYP2C9—Capecitabine—kidney cancer	0.00754	0.0271	CbGbCtD
Ifosfamide—CYP2C8—Erlotinib—kidney cancer	0.0074	0.0266	CbGbCtD
Ifosfamide—CYP3A5—Paclitaxel—kidney cancer	0.00704	0.0253	CbGbCtD
Ifosfamide—CYP2C8—Paclitaxel—kidney cancer	0.00677	0.0244	CbGbCtD
Ifosfamide—CYP3A7—Sunitinib—kidney cancer	0.00676	0.0243	CbGbCtD
Ifosfamide—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00676	0.0243	CbGbCtD
Ifosfamide—CYP3A5—Sorafenib—kidney cancer	0.00626	0.0225	CbGbCtD
Ifosfamide—CYP3A5—Vincristine—kidney cancer	0.00607	0.0219	CbGbCtD
Ifosfamide—CYP2C8—Sorafenib—kidney cancer	0.00601	0.0216	CbGbCtD
Ifosfamide—CYP3A5—Sunitinib—kidney cancer	0.00507	0.0182	CbGbCtD
Ifosfamide—CYP2C19—Sorafenib—kidney cancer	0.00505	0.0182	CbGbCtD
Ifosfamide—CYP2B6—Doxorubicin—kidney cancer	0.00482	0.0173	CbGbCtD
Ifosfamide—CYP2C9—Paclitaxel—kidney cancer	0.00472	0.017	CbGbCtD
Ifosfamide—CYP3A4—Pazopanib—kidney cancer	0.0042	0.0151	CbGbCtD
Ifosfamide—CYP2C9—Sorafenib—kidney cancer	0.0042	0.0151	CbGbCtD
Ifosfamide—CYP3A4—Erlotinib—kidney cancer	0.003	0.0108	CbGbCtD
Ifosfamide—CYP3A4—Paclitaxel—kidney cancer	0.00275	0.00988	CbGbCtD
Ifosfamide—CYP3A4—Sorafenib—kidney cancer	0.00244	0.00878	CbGbCtD
Ifosfamide—CYP3A4—Vinblastine—kidney cancer	0.00241	0.00867	CbGbCtD
Ifosfamide—CYP3A4—Vincristine—kidney cancer	0.00237	0.00852	CbGbCtD
Ifosfamide—CYP3A4—Sunitinib—kidney cancer	0.00198	0.00711	CbGbCtD
Ifosfamide—CYP3A4—Doxorubicin—kidney cancer	0.00148	0.00533	CbGbCtD
Ifosfamide—CYP2C19—urine—kidney cancer	0.000529	0.165	CbGeAlD
Ifosfamide—CYP2C9—urine—kidney cancer	0.00041	0.128	CbGeAlD
Ifosfamide—CYP3A4—urine—kidney cancer	0.000313	0.0977	CbGeAlD
Ifosfamide—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.000271	0.0847	CbGeAlD
Ifosfamide—Cyclophosphamide—ABCB1—kidney cancer	0.000251	1	CrCbGaD
Ifosfamide—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000232	0.0725	CbGeAlD
Ifosfamide—CYP2C8—renal system—kidney cancer	0.000113	0.0353	CbGeAlD
Ifosfamide—CYP3A5—nephron tubule—kidney cancer	0.000112	0.035	CbGeAlD
Ifosfamide—CYP2B6—nephron tubule—kidney cancer	0.000111	0.0348	CbGeAlD
Ifosfamide—CYP2C8—kidney—kidney cancer	0.000109	0.0341	CbGeAlD
Ifosfamide—CYP3A5—renal system—kidney cancer	0.000102	0.0319	CbGeAlD
Ifosfamide—CYP2B6—renal system—kidney cancer	0.000101	0.0317	CbGeAlD
Ifosfamide—CYP3A5—kidney—kidney cancer	9.85e-05	0.0308	CbGeAlD
Ifosfamide—CYP2B6—kidney—kidney cancer	9.79e-05	0.0306	CbGeAlD
Ifosfamide—CYP3A5—cortex of kidney—kidney cancer	9.6e-05	0.03	CbGeAlD
Ifosfamide—PTGS1—renal system—kidney cancer	9.16e-05	0.0286	CbGeAlD
Ifosfamide—CYP2B6—gonad—kidney cancer	9.08e-05	0.0284	CbGeAlD
Ifosfamide—PTGS1—kidney—kidney cancer	8.85e-05	0.0277	CbGeAlD
Ifosfamide—PTGS1—cardiac atrium—kidney cancer	8.2e-05	0.0256	CbGeAlD
Ifosfamide—CYP3A4—renal system—kidney cancer	7.65e-05	0.0239	CbGeAlD
Ifosfamide—CYP3A4—kidney—kidney cancer	7.39e-05	0.0231	CbGeAlD
Ifosfamide—Dermatitis—Erlotinib—kidney cancer	2.91e-05	0.000227	CcSEcCtD
Ifosfamide—Palpitations—Paclitaxel—kidney cancer	2.91e-05	0.000227	CcSEcCtD
Ifosfamide—Eye disorder—Capecitabine—kidney cancer	2.9e-05	0.000227	CcSEcCtD
Ifosfamide—Tinnitus—Capecitabine—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Pain—Vincristine—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Constipation—Vincristine—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Gastrointestinal haemorrhage—Doxorubicin—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Pain in extremity—Doxorubicin—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Osteoarthritis—Doxorubicin—kidney cancer	2.89e-05	0.000226	CcSEcCtD
Ifosfamide—Paraesthesia—Gemcitabine—kidney cancer	2.88e-05	0.000225	CcSEcCtD
Ifosfamide—Cardiac disorder—Capecitabine—kidney cancer	2.88e-05	0.000225	CcSEcCtD
Ifosfamide—Flushing—Capecitabine—kidney cancer	2.88e-05	0.000225	CcSEcCtD
Ifosfamide—Cough—Paclitaxel—kidney cancer	2.87e-05	0.000224	CcSEcCtD
Ifosfamide—Asthenia—Sunitinib—kidney cancer	2.87e-05	0.000224	CcSEcCtD
Ifosfamide—Dyspnoea—Gemcitabine—kidney cancer	2.86e-05	0.000224	CcSEcCtD
Ifosfamide—Nausea—Vinblastine—kidney cancer	2.86e-05	0.000223	CcSEcCtD
Ifosfamide—Somnolence—Gemcitabine—kidney cancer	2.85e-05	0.000223	CcSEcCtD
Ifosfamide—Convulsion—Paclitaxel—kidney cancer	2.85e-05	0.000223	CcSEcCtD
Ifosfamide—Nausea—Everolimus—kidney cancer	2.85e-05	0.000222	CcSEcCtD
Ifosfamide—Diarrhoea—Sorafenib—kidney cancer	2.84e-05	0.000222	CcSEcCtD
Ifosfamide—Hypertension—Paclitaxel—kidney cancer	2.84e-05	0.000222	CcSEcCtD
Ifosfamide—Pruritus—Sunitinib—kidney cancer	2.83e-05	0.000221	CcSEcCtD
Ifosfamide—Angiopathy—Capecitabine—kidney cancer	2.82e-05	0.00022	CcSEcCtD
Ifosfamide—Immune system disorder—Capecitabine—kidney cancer	2.8e-05	0.000219	CcSEcCtD
Ifosfamide—Myalgia—Paclitaxel—kidney cancer	2.8e-05	0.000219	CcSEcCtD
Ifosfamide—Arthralgia—Paclitaxel—kidney cancer	2.8e-05	0.000219	CcSEcCtD
Ifosfamide—Chest pain—Paclitaxel—kidney cancer	2.8e-05	0.000219	CcSEcCtD
Ifosfamide—Mediastinal disorder—Capecitabine—kidney cancer	2.8e-05	0.000219	CcSEcCtD
Ifosfamide—Decreased appetite—Gemcitabine—kidney cancer	2.79e-05	0.000218	CcSEcCtD
Ifosfamide—Hypersensitivity—Dactinomycin—kidney cancer	2.79e-05	0.000218	CcSEcCtD
Ifosfamide—Chills—Capecitabine—kidney cancer	2.79e-05	0.000218	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	2.78e-05	0.000217	CcSEcCtD
Ifosfamide—Arrhythmia—Capecitabine—kidney cancer	2.77e-05	0.000217	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Gemcitabine—kidney cancer	2.77e-05	0.000216	CcSEcCtD
Ifosfamide—Discomfort—Paclitaxel—kidney cancer	2.77e-05	0.000216	CcSEcCtD
Ifosfamide—Fatigue—Gemcitabine—kidney cancer	2.77e-05	0.000216	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Vincristine—kidney cancer	2.77e-05	0.000216	CcSEcCtD
Ifosfamide—Cardiac arrest—Doxorubicin—kidney cancer	2.75e-05	0.000215	CcSEcCtD
Ifosfamide—Dizziness—Sorafenib—kidney cancer	2.75e-05	0.000215	CcSEcCtD
Ifosfamide—Constipation—Gemcitabine—kidney cancer	2.75e-05	0.000214	CcSEcCtD
Ifosfamide—Pain—Gemcitabine—kidney cancer	2.75e-05	0.000214	CcSEcCtD
Ifosfamide—Nausea—Erlotinib—kidney cancer	2.75e-05	0.000214	CcSEcCtD
Ifosfamide—Alopecia—Capecitabine—kidney cancer	2.74e-05	0.000214	CcSEcCtD
Ifosfamide—Diarrhoea—Sunitinib—kidney cancer	2.74e-05	0.000214	CcSEcCtD
Ifosfamide—Mental disorder—Capecitabine—kidney cancer	2.72e-05	0.000212	CcSEcCtD
Ifosfamide—Asthenia—Dactinomycin—kidney cancer	2.72e-05	0.000212	CcSEcCtD
Ifosfamide—Confusional state—Paclitaxel—kidney cancer	2.71e-05	0.000212	CcSEcCtD
Ifosfamide—Blood creatinine increased—Doxorubicin—kidney cancer	2.71e-05	0.000212	CcSEcCtD
Ifosfamide—Erythema—Capecitabine—kidney cancer	2.7e-05	0.000211	CcSEcCtD
Ifosfamide—Malnutrition—Capecitabine—kidney cancer	2.7e-05	0.000211	CcSEcCtD
Ifosfamide—Anaphylactic shock—Paclitaxel—kidney cancer	2.69e-05	0.00021	CcSEcCtD
Ifosfamide—Oedema—Paclitaxel—kidney cancer	2.69e-05	0.00021	CcSEcCtD
Ifosfamide—Abdominal pain—Vincristine—kidney cancer	2.67e-05	0.000209	CcSEcCtD
Ifosfamide—Body temperature increased—Vincristine—kidney cancer	2.67e-05	0.000209	CcSEcCtD
Ifosfamide—Infection—Paclitaxel—kidney cancer	2.67e-05	0.000209	CcSEcCtD
Ifosfamide—Dizziness—Sunitinib—kidney cancer	2.65e-05	0.000207	CcSEcCtD
Ifosfamide—Feeling abnormal—Gemcitabine—kidney cancer	2.65e-05	0.000207	CcSEcCtD
Ifosfamide—Vomiting—Sorafenib—kidney cancer	2.64e-05	0.000206	CcSEcCtD
Ifosfamide—Nervous system disorder—Paclitaxel—kidney cancer	2.64e-05	0.000206	CcSEcCtD
Ifosfamide—Hypokalaemia—Doxorubicin—kidney cancer	2.63e-05	0.000206	CcSEcCtD
Ifosfamide—Thrombocytopenia—Paclitaxel—kidney cancer	2.63e-05	0.000206	CcSEcCtD
Ifosfamide—Rash—Sorafenib—kidney cancer	2.62e-05	0.000205	CcSEcCtD
Ifosfamide—Dermatitis—Sorafenib—kidney cancer	2.62e-05	0.000205	CcSEcCtD
Ifosfamide—Breast disorder—Doxorubicin—kidney cancer	2.61e-05	0.000204	CcSEcCtD
Ifosfamide—Skin disorder—Paclitaxel—kidney cancer	2.61e-05	0.000204	CcSEcCtD
Ifosfamide—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	2.6e-05	0.000203	CcSEcCtD
Ifosfamide—Hyperhidrosis—Paclitaxel—kidney cancer	2.6e-05	0.000203	CcSEcCtD
Ifosfamide—Diarrhoea—Dactinomycin—kidney cancer	2.59e-05	0.000202	CcSEcCtD
Ifosfamide—Anorexia—Paclitaxel—kidney cancer	2.56e-05	0.0002	CcSEcCtD
Ifosfamide—Vision blurred—Capecitabine—kidney cancer	2.55e-05	0.000199	CcSEcCtD
Ifosfamide—Vomiting—Sunitinib—kidney cancer	2.54e-05	0.000199	CcSEcCtD
Ifosfamide—Body temperature increased—Gemcitabine—kidney cancer	2.54e-05	0.000198	CcSEcCtD
Ifosfamide—Rash—Sunitinib—kidney cancer	2.52e-05	0.000197	CcSEcCtD
Ifosfamide—Dermatitis—Sunitinib—kidney cancer	2.52e-05	0.000197	CcSEcCtD
Ifosfamide—Hypotension—Paclitaxel—kidney cancer	2.51e-05	0.000196	CcSEcCtD
Ifosfamide—Ill-defined disorder—Capecitabine—kidney cancer	2.51e-05	0.000196	CcSEcCtD
Ifosfamide—Anaemia—Capecitabine—kidney cancer	2.5e-05	0.000195	CcSEcCtD
Ifosfamide—Hypersensitivity—Vincristine—kidney cancer	2.49e-05	0.000195	CcSEcCtD
Ifosfamide—Nausea—Sorafenib—kidney cancer	2.47e-05	0.000193	CcSEcCtD
Ifosfamide—Pancreatitis—Doxorubicin—kidney cancer	2.45e-05	0.000191	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Paclitaxel—kidney cancer	2.45e-05	0.000191	CcSEcCtD
Ifosfamide—Malaise—Capecitabine—kidney cancer	2.44e-05	0.00019	CcSEcCtD
Ifosfamide—Angina pectoris—Doxorubicin—kidney cancer	2.44e-05	0.00019	CcSEcCtD
Ifosfamide—Vertigo—Capecitabine—kidney cancer	2.43e-05	0.00019	CcSEcCtD
Ifosfamide—Asthenia—Vincristine—kidney cancer	2.43e-05	0.00019	CcSEcCtD
Ifosfamide—Leukopenia—Capecitabine—kidney cancer	2.42e-05	0.000189	CcSEcCtD
Ifosfamide—Paraesthesia—Paclitaxel—kidney cancer	2.41e-05	0.000188	CcSEcCtD
Ifosfamide—Vomiting—Dactinomycin—kidney cancer	2.41e-05	0.000188	CcSEcCtD
Ifosfamide—Dyspnoea—Paclitaxel—kidney cancer	2.4e-05	0.000187	CcSEcCtD
Ifosfamide—Somnolence—Paclitaxel—kidney cancer	2.39e-05	0.000187	CcSEcCtD
Ifosfamide—Palpitations—Capecitabine—kidney cancer	2.39e-05	0.000187	CcSEcCtD
Ifosfamide—Rash—Dactinomycin—kidney cancer	2.39e-05	0.000187	CcSEcCtD
Ifosfamide—Nausea—Sunitinib—kidney cancer	2.38e-05	0.000186	CcSEcCtD
Ifosfamide—Pancytopenia—Doxorubicin—kidney cancer	2.37e-05	0.000185	CcSEcCtD
Ifosfamide—Cough—Capecitabine—kidney cancer	2.36e-05	0.000184	CcSEcCtD
Ifosfamide—Dysuria—Doxorubicin—kidney cancer	2.34e-05	0.000183	CcSEcCtD
Ifosfamide—Decreased appetite—Paclitaxel—kidney cancer	2.34e-05	0.000182	CcSEcCtD
Ifosfamide—Hypertension—Capecitabine—kidney cancer	2.33e-05	0.000182	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Paclitaxel—kidney cancer	2.32e-05	0.000181	CcSEcCtD
Ifosfamide—Fatigue—Paclitaxel—kidney cancer	2.32e-05	0.000181	CcSEcCtD
Ifosfamide—Diarrhoea—Vincristine—kidney cancer	2.32e-05	0.000181	CcSEcCtD
Ifosfamide—Pollakiuria—Doxorubicin—kidney cancer	2.31e-05	0.00018	CcSEcCtD
Ifosfamide—Asthenia—Gemcitabine—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Myalgia—Capecitabine—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Chest pain—Capecitabine—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Arthralgia—Capecitabine—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Pain—Paclitaxel—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Constipation—Paclitaxel—kidney cancer	2.3e-05	0.00018	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	2.28e-05	0.000178	CcSEcCtD
Ifosfamide—Discomfort—Capecitabine—kidney cancer	2.27e-05	0.000178	CcSEcCtD
Ifosfamide—Pruritus—Gemcitabine—kidney cancer	2.27e-05	0.000177	CcSEcCtD
Ifosfamide—Hyperglycaemia—Doxorubicin—kidney cancer	2.26e-05	0.000176	CcSEcCtD
Ifosfamide—Nausea—Dactinomycin—kidney cancer	2.25e-05	0.000176	CcSEcCtD
Ifosfamide—Pneumonia—Doxorubicin—kidney cancer	2.24e-05	0.000175	CcSEcCtD
Ifosfamide—Dizziness—Vincristine—kidney cancer	2.24e-05	0.000175	CcSEcCtD
Ifosfamide—Infestation NOS—Doxorubicin—kidney cancer	2.23e-05	0.000174	CcSEcCtD
Ifosfamide—Infestation—Doxorubicin—kidney cancer	2.23e-05	0.000174	CcSEcCtD
Ifosfamide—Confusional state—Capecitabine—kidney cancer	2.22e-05	0.000174	CcSEcCtD
Ifosfamide—Feeling abnormal—Paclitaxel—kidney cancer	2.21e-05	0.000173	CcSEcCtD
Ifosfamide—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	2.21e-05	0.000173	CcSEcCtD
Ifosfamide—Oedema—Capecitabine—kidney cancer	2.21e-05	0.000172	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Paclitaxel—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Ifosfamide—Diarrhoea—Gemcitabine—kidney cancer	2.2e-05	0.000172	CcSEcCtD
Ifosfamide—Renal failure—Doxorubicin—kidney cancer	2.19e-05	0.000171	CcSEcCtD
Ifosfamide—Infection—Capecitabine—kidney cancer	2.19e-05	0.000171	CcSEcCtD
Ifosfamide—Neuropathy peripheral—Doxorubicin—kidney cancer	2.19e-05	0.000171	CcSEcCtD
Ifosfamide—Stomatitis—Doxorubicin—kidney cancer	2.17e-05	0.00017	CcSEcCtD
Ifosfamide—Conjunctivitis—Doxorubicin—kidney cancer	2.17e-05	0.000169	CcSEcCtD
Ifosfamide—Nervous system disorder—Capecitabine—kidney cancer	2.16e-05	0.000169	CcSEcCtD
Ifosfamide—Thrombocytopenia—Capecitabine—kidney cancer	2.16e-05	0.000169	CcSEcCtD
Ifosfamide—Vomiting—Vincristine—kidney cancer	2.15e-05	0.000168	CcSEcCtD
Ifosfamide—Skin disorder—Capecitabine—kidney cancer	2.14e-05	0.000167	CcSEcCtD
Ifosfamide—Urticaria—Paclitaxel—kidney cancer	2.14e-05	0.000167	CcSEcCtD
Ifosfamide—Rash—Vincristine—kidney cancer	2.13e-05	0.000167	CcSEcCtD
Ifosfamide—Hyperhidrosis—Capecitabine—kidney cancer	2.13e-05	0.000167	CcSEcCtD
Ifosfamide—Dermatitis—Vincristine—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Ifosfamide—Haematuria—Doxorubicin—kidney cancer	2.13e-05	0.000166	CcSEcCtD
Ifosfamide—Body temperature increased—Paclitaxel—kidney cancer	2.12e-05	0.000166	CcSEcCtD
Ifosfamide—Abdominal pain—Paclitaxel—kidney cancer	2.12e-05	0.000166	CcSEcCtD
Ifosfamide—Hepatobiliary disease—Doxorubicin—kidney cancer	2.11e-05	0.000165	CcSEcCtD
Ifosfamide—Anorexia—Capecitabine—kidney cancer	2.1e-05	0.000164	CcSEcCtD
Ifosfamide—Agranulocytosis—Doxorubicin—kidney cancer	2.08e-05	0.000162	CcSEcCtD
Ifosfamide—Hypotension—Capecitabine—kidney cancer	2.06e-05	0.000161	CcSEcCtD
Ifosfamide—Vomiting—Gemcitabine—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Ifosfamide—Bradycardia—Doxorubicin—kidney cancer	2.04e-05	0.000159	CcSEcCtD
Ifosfamide—Rash—Gemcitabine—kidney cancer	2.02e-05	0.000158	CcSEcCtD
Ifosfamide—Dermatitis—Gemcitabine—kidney cancer	2.02e-05	0.000158	CcSEcCtD
Ifosfamide—Haemoglobin—Doxorubicin—kidney cancer	2.01e-05	0.000157	CcSEcCtD
Ifosfamide—Nausea—Vincristine—kidney cancer	2.01e-05	0.000157	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Capecitabine—kidney cancer	2.01e-05	0.000157	CcSEcCtD
Ifosfamide—Haemorrhage—Doxorubicin—kidney cancer	2e-05	0.000156	CcSEcCtD
Ifosfamide—Hepatitis—Doxorubicin—kidney cancer	2e-05	0.000156	CcSEcCtD
Ifosfamide—Paraesthesia—Capecitabine—kidney cancer	1.98e-05	0.000155	CcSEcCtD
Ifosfamide—Hypersensitivity—Paclitaxel—kidney cancer	1.98e-05	0.000155	CcSEcCtD
Ifosfamide—Urinary tract disorder—Doxorubicin—kidney cancer	1.98e-05	0.000154	CcSEcCtD
Ifosfamide—Connective tissue disorder—Doxorubicin—kidney cancer	1.97e-05	0.000154	CcSEcCtD
Ifosfamide—Dyspnoea—Capecitabine—kidney cancer	1.97e-05	0.000154	CcSEcCtD
Ifosfamide—Urethral disorder—Doxorubicin—kidney cancer	1.96e-05	0.000153	CcSEcCtD
Ifosfamide—Visual impairment—Doxorubicin—kidney cancer	1.93e-05	0.000151	CcSEcCtD
Ifosfamide—Asthenia—Paclitaxel—kidney cancer	1.93e-05	0.000151	CcSEcCtD
Ifosfamide—Decreased appetite—Capecitabine—kidney cancer	1.92e-05	0.00015	CcSEcCtD
Ifosfamide—Nausea—Gemcitabine—kidney cancer	1.91e-05	0.000149	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Capecitabine—kidney cancer	1.9e-05	0.000149	CcSEcCtD
Ifosfamide—Fatigue—Capecitabine—kidney cancer	1.9e-05	0.000149	CcSEcCtD
Ifosfamide—Pruritus—Paclitaxel—kidney cancer	1.9e-05	0.000149	CcSEcCtD
Ifosfamide—Erythema multiforme—Doxorubicin—kidney cancer	1.89e-05	0.000148	CcSEcCtD
Ifosfamide—Pain—Capecitabine—kidney cancer	1.89e-05	0.000147	CcSEcCtD
Ifosfamide—Constipation—Capecitabine—kidney cancer	1.89e-05	0.000147	CcSEcCtD
Ifosfamide—Eye disorder—Doxorubicin—kidney cancer	1.87e-05	0.000146	CcSEcCtD
Ifosfamide—Tinnitus—Doxorubicin—kidney cancer	1.87e-05	0.000146	CcSEcCtD
Ifosfamide—Flushing—Doxorubicin—kidney cancer	1.86e-05	0.000145	CcSEcCtD
Ifosfamide—Cardiac disorder—Doxorubicin—kidney cancer	1.86e-05	0.000145	CcSEcCtD
Ifosfamide—Diarrhoea—Paclitaxel—kidney cancer	1.84e-05	0.000144	CcSEcCtD
Ifosfamide—Feeling abnormal—Capecitabine—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Ifosfamide—Angiopathy—Doxorubicin—kidney cancer	1.82e-05	0.000142	CcSEcCtD
Ifosfamide—Immune system disorder—Doxorubicin—kidney cancer	1.81e-05	0.000141	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Capecitabine—kidney cancer	1.8e-05	0.000141	CcSEcCtD
Ifosfamide—Mediastinal disorder—Doxorubicin—kidney cancer	1.8e-05	0.000141	CcSEcCtD
Ifosfamide—Chills—Doxorubicin—kidney cancer	1.8e-05	0.00014	CcSEcCtD
Ifosfamide—Arrhythmia—Doxorubicin—kidney cancer	1.79e-05	0.00014	CcSEcCtD
Ifosfamide—Dizziness—Paclitaxel—kidney cancer	1.78e-05	0.000139	CcSEcCtD
Ifosfamide—Alopecia—Doxorubicin—kidney cancer	1.77e-05	0.000138	CcSEcCtD
Ifosfamide—Mental disorder—Doxorubicin—kidney cancer	1.75e-05	0.000137	CcSEcCtD
Ifosfamide—Urticaria—Capecitabine—kidney cancer	1.75e-05	0.000137	CcSEcCtD
Ifosfamide—Abdominal pain—Capecitabine—kidney cancer	1.74e-05	0.000136	CcSEcCtD
Ifosfamide—Body temperature increased—Capecitabine—kidney cancer	1.74e-05	0.000136	CcSEcCtD
Ifosfamide—Erythema—Doxorubicin—kidney cancer	1.74e-05	0.000136	CcSEcCtD
Ifosfamide—Malnutrition—Doxorubicin—kidney cancer	1.74e-05	0.000136	CcSEcCtD
Ifosfamide—Vomiting—Paclitaxel—kidney cancer	1.71e-05	0.000133	CcSEcCtD
Ifosfamide—Rash—Paclitaxel—kidney cancer	1.69e-05	0.000132	CcSEcCtD
Ifosfamide—Dermatitis—Paclitaxel—kidney cancer	1.69e-05	0.000132	CcSEcCtD
Ifosfamide—Vision blurred—Doxorubicin—kidney cancer	1.64e-05	0.000128	CcSEcCtD
Ifosfamide—Hypersensitivity—Capecitabine—kidney cancer	1.62e-05	0.000127	CcSEcCtD
Ifosfamide—Ill-defined disorder—Doxorubicin—kidney cancer	1.62e-05	0.000126	CcSEcCtD
Ifosfamide—Anaemia—Doxorubicin—kidney cancer	1.61e-05	0.000126	CcSEcCtD
Ifosfamide—Agitation—Doxorubicin—kidney cancer	1.6e-05	0.000125	CcSEcCtD
Ifosfamide—Nausea—Paclitaxel—kidney cancer	1.6e-05	0.000125	CcSEcCtD
Ifosfamide—Asthenia—Capecitabine—kidney cancer	1.58e-05	0.000124	CcSEcCtD
Ifosfamide—Malaise—Doxorubicin—kidney cancer	1.57e-05	0.000123	CcSEcCtD
Ifosfamide—Vertigo—Doxorubicin—kidney cancer	1.57e-05	0.000122	CcSEcCtD
Ifosfamide—Pruritus—Capecitabine—kidney cancer	1.56e-05	0.000122	CcSEcCtD
Ifosfamide—Leukopenia—Doxorubicin—kidney cancer	1.56e-05	0.000122	CcSEcCtD
Ifosfamide—Palpitations—Doxorubicin—kidney cancer	1.54e-05	0.00012	CcSEcCtD
Ifosfamide—Cough—Doxorubicin—kidney cancer	1.52e-05	0.000119	CcSEcCtD
Ifosfamide—Convulsion—Doxorubicin—kidney cancer	1.51e-05	0.000118	CcSEcCtD
Ifosfamide—Diarrhoea—Capecitabine—kidney cancer	1.51e-05	0.000118	CcSEcCtD
Ifosfamide—Hypertension—Doxorubicin—kidney cancer	1.5e-05	0.000117	CcSEcCtD
Ifosfamide—Chest pain—Doxorubicin—kidney cancer	1.48e-05	0.000116	CcSEcCtD
Ifosfamide—Arthralgia—Doxorubicin—kidney cancer	1.48e-05	0.000116	CcSEcCtD
Ifosfamide—Myalgia—Doxorubicin—kidney cancer	1.48e-05	0.000116	CcSEcCtD
Ifosfamide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	1.47e-05	0.000115	CcSEcCtD
Ifosfamide—Discomfort—Doxorubicin—kidney cancer	1.47e-05	0.000114	CcSEcCtD
Ifosfamide—Dizziness—Capecitabine—kidney cancer	1.46e-05	0.000114	CcSEcCtD
Ifosfamide—Confusional state—Doxorubicin—kidney cancer	1.43e-05	0.000112	CcSEcCtD
Ifosfamide—Anaphylactic shock—Doxorubicin—kidney cancer	1.42e-05	0.000111	CcSEcCtD
Ifosfamide—Oedema—Doxorubicin—kidney cancer	1.42e-05	0.000111	CcSEcCtD
Ifosfamide—Infection—Doxorubicin—kidney cancer	1.41e-05	0.00011	CcSEcCtD
Ifosfamide—Vomiting—Capecitabine—kidney cancer	1.4e-05	0.00011	CcSEcCtD
Ifosfamide—Nervous system disorder—Doxorubicin—kidney cancer	1.39e-05	0.000109	CcSEcCtD
Ifosfamide—Thrombocytopenia—Doxorubicin—kidney cancer	1.39e-05	0.000109	CcSEcCtD
Ifosfamide—Rash—Capecitabine—kidney cancer	1.39e-05	0.000109	CcSEcCtD
Ifosfamide—Dermatitis—Capecitabine—kidney cancer	1.39e-05	0.000109	CcSEcCtD
Ifosfamide—Skin disorder—Doxorubicin—kidney cancer	1.38e-05	0.000108	CcSEcCtD
Ifosfamide—Hyperhidrosis—Doxorubicin—kidney cancer	1.37e-05	0.000107	CcSEcCtD
Ifosfamide—Anorexia—Doxorubicin—kidney cancer	1.36e-05	0.000106	CcSEcCtD
Ifosfamide—Hypotension—Doxorubicin—kidney cancer	1.33e-05	0.000104	CcSEcCtD
Ifosfamide—Nausea—Capecitabine—kidney cancer	1.31e-05	0.000102	CcSEcCtD
Ifosfamide—Musculoskeletal discomfort—Doxorubicin—kidney cancer	1.3e-05	0.000101	CcSEcCtD
Ifosfamide—Paraesthesia—Doxorubicin—kidney cancer	1.28e-05	9.97e-05	CcSEcCtD
Ifosfamide—Dyspnoea—Doxorubicin—kidney cancer	1.27e-05	9.9e-05	CcSEcCtD
Ifosfamide—Somnolence—Doxorubicin—kidney cancer	1.26e-05	9.87e-05	CcSEcCtD
Ifosfamide—Decreased appetite—Doxorubicin—kidney cancer	1.24e-05	9.65e-05	CcSEcCtD
Ifosfamide—Gastrointestinal disorder—Doxorubicin—kidney cancer	1.23e-05	9.59e-05	CcSEcCtD
Ifosfamide—Fatigue—Doxorubicin—kidney cancer	1.23e-05	9.57e-05	CcSEcCtD
Ifosfamide—Pain—Doxorubicin—kidney cancer	1.22e-05	9.5e-05	CcSEcCtD
Ifosfamide—Constipation—Doxorubicin—kidney cancer	1.22e-05	9.5e-05	CcSEcCtD
Ifosfamide—Feeling abnormal—Doxorubicin—kidney cancer	1.17e-05	9.15e-05	CcSEcCtD
Ifosfamide—Gastrointestinal pain—Doxorubicin—kidney cancer	1.16e-05	9.08e-05	CcSEcCtD
Ifosfamide—Urticaria—Doxorubicin—kidney cancer	1.13e-05	8.82e-05	CcSEcCtD
Ifosfamide—Body temperature increased—Doxorubicin—kidney cancer	1.12e-05	8.78e-05	CcSEcCtD
Ifosfamide—Abdominal pain—Doxorubicin—kidney cancer	1.12e-05	8.78e-05	CcSEcCtD
Ifosfamide—Hypersensitivity—Doxorubicin—kidney cancer	1.05e-05	8.18e-05	CcSEcCtD
Ifosfamide—Asthenia—Doxorubicin—kidney cancer	1.02e-05	7.97e-05	CcSEcCtD
Ifosfamide—Pruritus—Doxorubicin—kidney cancer	1.01e-05	7.86e-05	CcSEcCtD
Ifosfamide—Diarrhoea—Doxorubicin—kidney cancer	9.73e-06	7.6e-05	CcSEcCtD
Ifosfamide—Dizziness—Doxorubicin—kidney cancer	9.4e-06	7.34e-05	CcSEcCtD
Ifosfamide—Vomiting—Doxorubicin—kidney cancer	9.04e-06	7.06e-05	CcSEcCtD
Ifosfamide—Rash—Doxorubicin—kidney cancer	8.96e-06	7e-05	CcSEcCtD
Ifosfamide—Dermatitis—Doxorubicin—kidney cancer	8.96e-06	7e-05	CcSEcCtD
Ifosfamide—Nausea—Doxorubicin—kidney cancer	8.44e-06	6.6e-05	CcSEcCtD
Ifosfamide—CYP3A7—Metabolism—CRABP1—kidney cancer	7.54e-06	0.000431	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC5A3—kidney cancer	7.54e-06	0.000431	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PGK1—kidney cancer	7.54e-06	0.000431	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GPC3—kidney cancer	7.53e-06	0.000431	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	7.51e-06	0.00043	CbGpPWpGaD
Ifosfamide—CYP3A4—Metapathway biotransformation—CYP1A1—kidney cancer	7.48e-06	0.000428	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—LDHB—kidney cancer	7.39e-06	0.000423	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CA2—kidney cancer	7.32e-06	0.000419	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—ACHE—kidney cancer	7.31e-06	0.000418	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CRABP1—kidney cancer	7.31e-06	0.000418	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—FH—kidney cancer	7.15e-06	0.000409	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—APRT—kidney cancer	7.15e-06	0.000409	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALAD—kidney cancer	7.14e-06	0.000408	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GLIPR1—kidney cancer	7.01e-06	0.000401	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PPAT—kidney cancer	7.01e-06	0.000401	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ITPR2—kidney cancer	7.01e-06	0.000401	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.99e-06	0.0004	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ST3GAL2—kidney cancer	6.97e-06	0.000399	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—SCARB1—kidney cancer	6.92e-06	0.000396	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CRABP1—kidney cancer	6.91e-06	0.000395	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS1—kidney cancer	6.85e-06	0.000392	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ALDH1A1—kidney cancer	6.81e-06	0.00039	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ITPR2—kidney cancer	6.79e-06	0.000389	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GPC3—kidney cancer	6.72e-06	0.000385	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ACY1—kidney cancer	6.67e-06	0.000382	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTP1—kidney cancer	6.66e-06	0.000381	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CA9—kidney cancer	6.56e-06	0.000375	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CA2—kidney cancer	6.54e-06	0.000374	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PGK1—kidney cancer	6.53e-06	0.000374	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC5A3—kidney cancer	6.53e-06	0.000374	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—APRT—kidney cancer	6.52e-06	0.000373	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—FH—kidney cancer	6.52e-06	0.000373	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ITPR2—kidney cancer	6.42e-06	0.000368	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CA9—kidney cancer	6.41e-06	0.000367	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—LDHB—kidney cancer	6.4e-06	0.000366	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTT1—kidney cancer	6.39e-06	0.000366	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ACHE—kidney cancer	6.39e-06	0.000366	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALAD—kidney cancer	6.37e-06	0.000365	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	6.37e-06	0.000365	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—ABCB1—kidney cancer	6.31e-06	0.000361	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.26e-06	0.000358	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ST3GAL2—kidney cancer	6.22e-06	0.000356	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ACHE—kidney cancer	6.19e-06	0.000355	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTT1—kidney cancer	6.19e-06	0.000355	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GPC3—kidney cancer	6.13e-06	0.000351	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—GSTM1—kidney cancer	6.12e-06	0.00035	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ALDH1A1—kidney cancer	6.08e-06	0.000348	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SCARB1—kidney cancer	6.05e-06	0.000346	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS1—kidney cancer	5.99e-06	0.000343	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CA2—kidney cancer	5.96e-06	0.000341	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PSMD7—kidney cancer	5.87e-06	0.000336	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SCARB1—kidney cancer	5.86e-06	0.000336	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTT1—kidney cancer	5.86e-06	0.000335	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ACHE—kidney cancer	5.86e-06	0.000335	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PGK1—kidney cancer	5.83e-06	0.000333	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A3—kidney cancer	5.83e-06	0.000333	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALAD—kidney cancer	5.81e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—CYP1A1—kidney cancer	5.8e-06	0.000332	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—LDHB—kidney cancer	5.71e-06	0.000327	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PSMD7—kidney cancer	5.69e-06	0.000326	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PDHB—kidney cancer	5.67e-06	0.000325	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ST3GAL2—kidney cancer	5.67e-06	0.000324	CbGpPWpGaD
Ifosfamide—CYP3A4—Biological oxidations—POMC—kidney cancer	5.65e-06	0.000324	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CRABP1—kidney cancer	5.57e-06	0.000319	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—BCHE—kidney cancer	5.57e-06	0.000319	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CA9—kidney cancer	5.55e-06	0.000318	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SCARB1—kidney cancer	5.54e-06	0.000317	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ALDH1A1—kidney cancer	5.54e-06	0.000317	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SLC5A5—kidney cancer	5.5e-06	0.000315	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS1—kidney cancer	5.49e-06	0.000314	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CRABP1—kidney cancer	5.45e-06	0.000312	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.43e-06	0.00031	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—BCHE—kidney cancer	5.4e-06	0.000309	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PSMD7—kidney cancer	5.38e-06	0.000308	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CCBL1—kidney cancer	5.33e-06	0.000305	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SLC5A5—kidney cancer	5.33e-06	0.000305	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PGK1—kidney cancer	5.31e-06	0.000304	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A3—kidney cancer	5.31e-06	0.000304	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—SLC2A1—kidney cancer	5.31e-06	0.000304	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—LDHB—kidney cancer	5.21e-06	0.000298	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ITPR2—kidney cancer	5.18e-06	0.000297	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—SLC2A1—kidney cancer	5.15e-06	0.000295	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—BCHE—kidney cancer	5.1e-06	0.000292	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ITPR2—kidney cancer	5.07e-06	0.00029	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SLC5A5—kidney cancer	5.04e-06	0.000288	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.99e-06	0.000286	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CA9—kidney cancer	4.95e-06	0.000284	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—SLC2A1—kidney cancer	4.87e-06	0.000279	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.84e-06	0.000277	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTT1—kidney cancer	4.73e-06	0.00027	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ACHE—kidney cancer	4.73e-06	0.00027	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CRABP1—kidney cancer	4.72e-06	0.00027	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GLIPR1—kidney cancer	4.62e-06	0.000265	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PPAT—kidney cancer	4.62e-06	0.000265	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTT1—kidney cancer	4.62e-06	0.000264	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ACHE—kidney cancer	4.62e-06	0.000264	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CA9—kidney cancer	4.52e-06	0.000259	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SCARB1—kidney cancer	4.47e-06	0.000256	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTP1—kidney cancer	4.43e-06	0.000254	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS1—kidney cancer	4.43e-06	0.000253	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	4.42e-06	0.000253	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ITPR2—kidney cancer	4.39e-06	0.000251	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SCARB1—kidney cancer	4.37e-06	0.00025	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.36e-06	0.000249	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PSMD7—kidney cancer	4.34e-06	0.000249	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS1—kidney cancer	4.33e-06	0.000248	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—POMC—kidney cancer	4.33e-06	0.000248	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—FH—kidney cancer	4.3e-06	0.000246	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—APRT—kidney cancer	4.3e-06	0.000246	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTP1—kidney cancer	4.29e-06	0.000246	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PSMD7—kidney cancer	4.25e-06	0.000243	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CRABP1—kidney cancer	4.21e-06	0.000241	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—ABCB1—kidney cancer	4.19e-06	0.00024	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—BCHE—kidney cancer	4.12e-06	0.000236	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—GSTM1—kidney cancer	4.07e-06	0.000233	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SLC5A5—kidney cancer	4.07e-06	0.000233	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—ABCB1—kidney cancer	4.06e-06	0.000233	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTP1—kidney cancer	4.06e-06	0.000232	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.04e-06	0.000231	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GPC3—kidney cancer	4.04e-06	0.000231	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—BCHE—kidney cancer	4.02e-06	0.00023	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTT1—kidney cancer	4e-06	0.000229	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ACHE—kidney cancer	4e-06	0.000229	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC5A5—kidney cancer	3.98e-06	0.000228	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—GSTM1—kidney cancer	3.95e-06	0.000226	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CA2—kidney cancer	3.93e-06	0.000225	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—SLC2A1—kidney cancer	3.93e-06	0.000225	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ITPR2—kidney cancer	3.92e-06	0.000224	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—CYP1A1—kidney cancer	3.86e-06	0.000221	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—ABCB1—kidney cancer	3.84e-06	0.00022	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CRABP1—kidney cancer	3.84e-06	0.00022	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—SLC2A1—kidney cancer	3.84e-06	0.00022	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALAD—kidney cancer	3.83e-06	0.000219	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SCARB1—kidney cancer	3.79e-06	0.000217	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS1—kidney cancer	3.75e-06	0.000215	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—CYP1A1—kidney cancer	3.74e-06	0.000214	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ST3GAL2—kidney cancer	3.74e-06	0.000214	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—GSTM1—kidney cancer	3.73e-06	0.000214	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PSMD7—kidney cancer	3.68e-06	0.00021	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ALDH1A1—kidney cancer	3.65e-06	0.000209	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.61e-06	0.000207	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ACHE—kidney cancer	3.57e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTT1—kidney cancer	3.57e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ITPR2—kidney cancer	3.57e-06	0.000204	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—CYP1A1—kidney cancer	3.54e-06	0.000202	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A3—kidney cancer	3.5e-06	0.000201	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PGK1—kidney cancer	3.5e-06	0.000201	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—BCHE—kidney cancer	3.49e-06	0.000199	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTGS2—kidney cancer	3.45e-06	0.000198	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC5A5—kidney cancer	3.44e-06	0.000197	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—LDHB—kidney cancer	3.44e-06	0.000197	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SCARB1—kidney cancer	3.38e-06	0.000193	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS1—kidney cancer	3.35e-06	0.000192	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—SLC2A1—kidney cancer	3.33e-06	0.00019	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	3.29e-06	0.000188	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PSMD7—kidney cancer	3.28e-06	0.000188	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTP1—kidney cancer	3.28e-06	0.000187	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTT1—kidney cancer	3.26e-06	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ACHE—kidney cancer	3.26e-06	0.000186	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.23e-06	0.000185	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTP1—kidney cancer	3.2e-06	0.000183	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—BCHE—kidney cancer	3.11e-06	0.000178	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—ABCB1—kidney cancer	3.1e-06	0.000177	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SCARB1—kidney cancer	3.08e-06	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC5A5—kidney cancer	3.07e-06	0.000176	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.07e-06	0.000176	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS1—kidney cancer	3.05e-06	0.000175	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—ABCB1—kidney cancer	3.03e-06	0.000173	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—GSTM1—kidney cancer	3.01e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PTEN—kidney cancer	3.01e-06	0.000172	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PSMD7—kidney cancer	2.99e-06	0.000171	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CA9—kidney cancer	2.98e-06	0.000171	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—SLC2A1—kidney cancer	2.97e-06	0.00017	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—GSTM1—kidney cancer	2.94e-06	0.000168	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.88e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—POMC—kidney cancer	2.88e-06	0.000165	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—CYP1A1—kidney cancer	2.85e-06	0.000163	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—BCHE—kidney cancer	2.84e-06	0.000162	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.81e-06	0.000161	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC5A5—kidney cancer	2.8e-06	0.00016	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—CYP1A1—kidney cancer	2.79e-06	0.00016	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—POMC—kidney cancer	2.79e-06	0.00016	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTP1—kidney cancer	2.77e-06	0.000159	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—SLC2A1—kidney cancer	2.71e-06	0.000155	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—POMC—kidney cancer	2.64e-06	0.000151	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	2.63e-06	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—ABCB1—kidney cancer	2.63e-06	0.00015	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—GSTM1—kidney cancer	2.55e-06	0.000146	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CRABP1—kidney cancer	2.53e-06	0.000145	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.51e-06	0.000144	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTP1—kidney cancer	2.48e-06	0.000142	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—CYP1A1—kidney cancer	2.42e-06	0.000138	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ITPR2—kidney cancer	2.36e-06	0.000135	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—ABCB1—kidney cancer	2.34e-06	0.000134	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTGS2—kidney cancer	2.29e-06	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.29e-06	0.000131	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—GSTM1—kidney cancer	2.27e-06	0.00013	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTP1—kidney cancer	2.26e-06	0.000129	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTGS2—kidney cancer	2.22e-06	0.000127	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—CYP1A1—kidney cancer	2.16e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTT1—kidney cancer	2.15e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ACHE—kidney cancer	2.15e-06	0.000123	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—ABCB1—kidney cancer	2.14e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—POMC—kidney cancer	2.13e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP2C18—Metabolism—PIK3CA—kidney cancer	2.12e-06	0.000122	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTGS2—kidney cancer	2.1e-06	0.00012	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—POMC—kidney cancer	2.08e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—GSTM1—kidney cancer	2.07e-06	0.000119	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SCARB1—kidney cancer	2.03e-06	0.000116	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS1—kidney cancer	2.01e-06	0.000115	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PTEN—kidney cancer	2e-06	0.000115	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.98e-06	0.000114	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PSMD7—kidney cancer	1.97e-06	0.000113	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—CYP1A1—kidney cancer	1.97e-06	0.000113	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PTEN—kidney cancer	1.94e-06	0.000111	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—BCHE—kidney cancer	1.87e-06	0.000107	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC5A5—kidney cancer	1.85e-06	0.000106	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PTEN—kidney cancer	1.83e-06	0.000105	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—POMC—kidney cancer	1.8e-06	0.000103	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—SLC2A1—kidney cancer	1.78e-06	0.000102	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.77e-06	0.000101	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTGS2—kidney cancer	1.7e-06	9.71e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTGS2—kidney cancer	1.66e-06	9.49e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	1.62e-06	9.25e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—POMC—kidney cancer	1.61e-06	9.2e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTP1—kidney cancer	1.49e-06	8.52e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PTEN—kidney cancer	1.48e-06	8.47e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—POMC—kidney cancer	1.47e-06	8.39e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PTEN—kidney cancer	1.45e-06	8.28e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTGS2—kidney cancer	1.44e-06	8.22e-05	CbGpPWpGaD
Ifosfamide—CYP3A7—Metabolism—PIK3CA—kidney cancer	1.41e-06	8.08e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—ABCB1—kidney cancer	1.41e-06	8.06e-05	CbGpPWpGaD
Ifosfamide—PTGS1—Metabolism—PIK3CA—kidney cancer	1.37e-06	7.83e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—GSTM1—kidney cancer	1.37e-06	7.83e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.3e-06	7.42e-05	CbGpPWpGaD
Ifosfamide—CYP2A6—Metabolism—PIK3CA—kidney cancer	1.29e-06	7.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTGS2—kidney cancer	1.28e-06	7.34e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PTEN—kidney cancer	1.25e-06	7.17e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTGS2—kidney cancer	1.17e-06	6.69e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PTEN—kidney cancer	1.12e-06	6.4e-05	CbGpPWpGaD
Ifosfamide—CYP2B6—Metabolism—PIK3CA—kidney cancer	1.04e-06	5.98e-05	CbGpPWpGaD
Ifosfamide—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.02e-06	5.84e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PTEN—kidney cancer	1.02e-06	5.84e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—POMC—kidney cancer	9.67e-07	5.53e-05	CbGpPWpGaD
Ifosfamide—CYP2C8—Metabolism—PIK3CA—kidney cancer	8.84e-07	5.06e-05	CbGpPWpGaD
Ifosfamide—CYP2C19—Metabolism—PIK3CA—kidney cancer	7.89e-07	4.52e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTGS2—kidney cancer	7.71e-07	4.41e-05	CbGpPWpGaD
Ifosfamide—CYP2C9—Metabolism—PIK3CA—kidney cancer	7.19e-07	4.12e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PTEN—kidney cancer	6.73e-07	3.85e-05	CbGpPWpGaD
Ifosfamide—CYP3A4—Metabolism—PIK3CA—kidney cancer	4.74e-07	2.72e-05	CbGpPWpGaD
